Phenotypic variations of TRAIL sensitivity in cloned populations of prostate cancer cells

Phenotypic variations of TRAIL sensitivity in cloned populations of prostate cancer cells

他のバージョン（1件）を表示する

Factors that regulate the induction of apoptosis of tumour cells are potential candidates for therapeutic intervention for the majority of cancers. Studying modifiers of apoptotic responses, such as members of the tumour necrosis factor receptor superfamily, may give clues as to how induction of apo...

書誌詳細
主要な著者:	Cross, N, Waterman, E, Jokonya, N, Fowles, A, Buckle, C, Phillips, J, Holen, I, Hamdy, F, Eaton, C
フォーマット:	Journal article
言語:	English
出版事項:	2008

類似資料

Phenotypic variations of TRAIL sensitivity in cloned populations of prostate cancer cells.
著者:: Cross, N, 等
出版事項: (2008)

Imaging the effects of castration on bone turnover and hormone-independent prostate cancer colonization of bone.
著者:: Cross, N, 等
出版事項: (2008)

Human bone marrow stromal cells protect prostate and breast cancer cells from TRAIL-induced apoptosis
著者:: Nyambo, R, 等
出版事項: (2004)

The expression and regulation of ADAMTS-1, -4, -5, -9, and -15, and TIMP-3 by TGFbeta1 in prostate cells: relevance to the accumulation of versican.
著者:: Cross, N, 等
出版事項: (2005)

Human bone marrow stromal cells protect prostate cancer cells from TRAIL-induced apoptosis.
著者:: Nyambo, R, 等
出版事項: (2004)

Analysis of the functional role of ADAMTS enzymes in prostate cancer
著者:: Molokwu, C, 等
出版事項: (2005)

The antibody MAB8051 directed against osteoprotegerin detects carbonic anhydrase II: implications for association studies with human cancers.
著者:: Waterman, E, 等
出版事項: (2007)

Osteoprotegerin (OPG) is a survival factor for human prostate cancer cells.
著者:: Holen, I, 等
出版事項: (2002)

Serum osteoprotegerin (OPG) levels and disease progression in prostate cancer patients
著者:: Eaton, C, 等
出版事項: (2004)

Expression pattern of the ADAMTS (A Disintegrin And Metalloproteinase with ThromboSpondin motifs) proteinases in human prostate cancer celllines
著者:: Chandrasekharan, S, 等
出版事項: (2003)

Osteoprotegerin is an anti-apoptotic factor produced by prostate cancer cells that is potentially involved in tumour survival and progression.
著者:: Holen, I, 等
出版事項: (2002)

Serum osteoprotegerin (OPG) levels are associated with disease progression and response to androgen ablation in patients with prostate cancer.
著者:: Eaton, C, 等
出版事項: (2004)

Human bone marrow stromal cell derived IGF signaling enhances PSA production as well as proliferation/survival of androgen sensitive prostate cancer cells in vitro
著者:: Papageorgiou, M, 等
出版事項: (2005)

EZH2 promotes proliferation and invasiveness of prostate cancer cells.
著者:: Bryant, R, 等
出版事項: (2007)

Evaluating the role of ADAMTS proteoglycanases and TIMP-3 in prostate cancer progression
著者:: Adeniji, O, 等
出版事項: (2007)

TIMP-3 expression is regulated by androgen and TNF in prostate stromal and cancer cells
著者:: Adeniji, O, 等
出版事項: (2008)

TIMP-3 expression in prostate stromal and tumour cells is regulated by androgen and TNF
著者:: Adeniji, O, 等
出版事項: (2007)

The role of osteoprotegerin in breast and prostate cancer
著者:: Holen, I, 等
出版事項: (2002)

BMP-6 over-expression in prostate cancer is associated with increased Id-1 protein and a more invasive phenotype.
著者:: Darby, S, 等
出版事項: (2008)

OPG is a survival factor for breast- and prostate cancer cells in vitro
著者:: Holen, I, 等
出版事項: (2002)

The polycomb group protein EZH2 is required for transcriptional repression of p21 and MMP7 in prostate cancer cells
著者:: Bryant, R, 等
出版事項: (2007)

Trailing TRAIL Resistance: Novel Targets for TRAIL sensitization in Cancer cells
著者:: RACHANA eTRIVEDI, 等
出版事項: (2015-04-01)

Overcoming TRAIL-resistance by sensitizing prostate cancer 3D spheroids with taxanes.
著者:: Korie A Grayson, 等
出版事項: (2021-01-01)

Qualitative and quantitative PSA mRNA detection in prostate cancer - A useful tool for the clinician?
著者:: Phillips, J, 等
出版事項: (2007)

Dystroglycan function is a novel determinant of tumor growth and behavior in prostate cancer.
著者:: Mitchell, A, 等
出版事項: (2013)

High susceptibility of metastatic cells derived from human prostate and colon cancer cells to TRAIL and sensitization of TRAIL-insensitive primary cells to TRAIL by 4,5-dimethoxy-2-nitrobenzaldehyde
著者:: Lee Jae-Won, 等
出版事項: (2011-04-01)

Bone marrow stromal cell-derived insulin-like growth factor (IGF) II enhances growth and survival of prostate cancer cells and potentiates androgen action
著者:: Cross, N, 等
出版事項: (2007)

Splicing reprogramming of TRAIL/DISC-components sensitizes lung cancer cells to TRAIL-mediated apoptosis
著者:: Oliver H. Voss, 等
出版事項: (2021-03-01)

HIV induces TRAIL sensitivity in hepatocytes.
著者:: Challagundla K Babu, 等
出版事項: (2009-01-01)

The emphysematous lung is abnormally sensitive to TRAIL-mediated apoptosis
著者:: Milot Julie, 等
出版事項: (2011-08-01)

Itraq-facilitated proteomic analysis of human prostate cancer cells identifies proteins associated with progression
著者:: Rehman, I, 等
出版事項: (2008)

Differential sensitivity of normal osteoblast-like cells and osteosarcoma cells to TRAIL and an agonist antibody to TRAIL receptor-2
著者:: Locklin, R, 等
出版事項: (2005)

iTRAQ-facilitated proteomic analysis of human prostate cancer cells identifies proteins associated with progression.
著者:: Glen, A, 等
出版事項: (2008)

Apigenin sensitizes prostate cancer cells to Apo2L/TRAIL by targeting adenine nucleotide translocase-2.
著者:: Masakatsu Oishi, 等
出版事項: (2013-01-01)

Trailing end-point phenotype antibiotic-sensitive strains of Candida albicans produce different amounts of aspartyl peptidases
著者:: L.A. Braga-Silva, 等
出版事項: (2009-08-01)

iTRAQ identification of candidate serum biomarkers associated with metastatic progression of human prostate cancer.
著者:: Rehman, I, 等
出版事項: (2012)

Diurnal variation of non-specular meteor trails
著者:: J. Hinrichs, 等
出版事項: (2009-05-01)

Global variation of meteor trail plasma turbulence
著者:: L. P. Dyrud, 等
出版事項: (2011-12-01)

Proteomic analysis of voided urine following prostatic massage reveals tumour specific alterations
著者:: Rehman, I, 等
出版事項: (2004)

Trail without Catheter after Transurethral Resection of Prostate: Clamp It or Not?
著者:: Vikash Talreja, 等
出版事項: (2016-01-01)